Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

OBJECTIVES: Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated a multi-biomarker disease activity (MBDA) score, based on 12 serum biomarkers as a baseline predictor for 1-year RP in eRA. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Hambardzumyan, Karen, Bolce, Rebecca, Saevarsdottir, Saedis, Cruickshank, Scott E, Sasso, Eric H, Chernoff, David, Forslind, Kristina, Petersson, Ingemar F, Geborek, Pierre, van Vollenhoven, Ronald F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431327/
https://www.ncbi.nlm.nih.gov/pubmed/24812287
http://dx.doi.org/10.1136/annrheumdis-2013-204986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431327/
https://www.ncbi.nlm.nih.gov/pubmed/24812287
http://dx.doi.org/10.1136/annrheumdis-2013-204986

Ejemplares similares